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Abstract 
The incidence of infection by Hepatitis A virus shows regional variation being high-
est in developing countries. Determination of age specific Hepatitis A virus (HAV) 
seroprevalence and the associated risk factors would help better plan for national 
preventive strategies including vaccination. We carried out a cross-sectional study on 
300 children from Nairobi city, Kenya during the years 2003-2004. The age range of 
the children was 2 - 14 years and were from low and high socioeconomic status (SES) 
families. The indicators of SES included employment status, residence, number of 
children per patient’s household, parents’ level of education and source of drinking 
water. SES was encoded and analysed using Statistical Program for Social Sciences 
(SSPS) version 16.0. Seroprevalence increased significantly with advancing age. Se-
ropositivity of HAV antibodies was significantly higher among children of low SES, 
77.6% by the age of 14 years compared to children of high SES, 38.9% by the same 
age. Crowded household and parental education were significantly associated with 
high seropositivity and seronegativity respectively. There is significant rate of sero-
negativity amongst the studied population especially those from richer backgrounds 
making them more susceptible to severe infection in future with concomitant com-
plications. We propose that revision of national vaccination program should be con-
sidered to include Hepatitis A vaccination. 
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1. Introduction 
The infection due to Hepatitis A virus (HAV) is on epidemiological transition globally 
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with changing patterns in respect with economic fortunes. Certain regions of the world 
are known to have the highest endemicity including Asia, Africa and parts of the Car-
ibbean, South, Central America. Economic factors leading to high endemic levels in-
clude lack of proper housing and water sanitation, overcrowding and poverty [1] [2]. 
The virus is transmitted via the feco-oral route and its exact impact is always underes-
timated due to mildly symptomatic or asymptomatic nature of the infection [3] [4]. 
There is considerable variation in the rates of seroprevalence by region, country and 
intra-country with marked fluctuations from time to time but in general the underde-
veloped countries bear the greatest disease burden amongst children at an earlier age. 
Coincidentally, these infections are mild to asymptomatic and most of the children at-
tain immunity by the time they reach adolescence [5]. On the contrary, developed 
countries are characterized by low antibody seroprevalence of HAV during childhood 
which continues to adulthood where roughly 50% of the adult population is seronega-
tive and consequently at risk of severe forms of hepatitis A infection [6] [7]. 
With improving economic fortunes of most developing nations, the epidemiologic 
pattern of HAV is expected to shift and may demonstrate patterns similar to those of 
developed countries. This has the potential of putting the adult population at risk of 
severe hepatitis A infection [8]. Although Hepatitis A virus infection can easily and ef-
fectively be mitigated through vaccination [9], this has not been fully implemented and 
included in the national vaccination programs of many countries including Kenya. As a 
result, there is likelihood of witnessing more adult morbidity and mortality resulting 
from HAV infection. This study aimed at determining the age specific HAV antibody 
seroprevalence and the associated risk factors which would help better plan for national 
preventive strategies including vaccination.  
2. Patients and Methods 
Three hundred children from Nairobi, Kenya aged between two and fourteen years 
without a history of vaccination against hepatitis A, signs of hepatitis or jaundice and 
had lived in the present accommodation or similar one in Nairobi from birth were in-
cluded in the study. This study was done between year 2003 and 2004 in Nairobi City, 
Kenya. Three hundred children were included in this study but only 256 were analysed. 
The sample size was calculated based on prevalence of previous studies and considering 
80% power. The children were subdivided into three age groups: 2 - 4, 5 - 9, 10 - 14 
years. 
Permission to carry out the study was obtained from Kenyatta National Hospital/ 
University of Nairobi Ethics and Review committee and the Aga Khan University Hos-
pital Education committee. Informed consent obtained from the parents before the 
children were included in the study. A structured questionnaire developed by the prin-
cipal investigator in this study and his team was used to collectd emographic data and 
evaluate the socioeconomic status (SES) of the subjects after pilot and proper validation 
of the tools. The indicators of SES included employment status, residence, number of 
children per patient’s household, parents’ level of education, source of drinking water.  
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Socioeconomic status (SES) was encoded and scored as summarized in Table 1: Each 
attribute was assigned 1 or 2 point(s) in column 1 and 2 respectively. Total score was 
then calculated. A score of 6 or less was deemed as high SES while a score of 7 - 12 was 
judged as low SES. 
Alongside the questionnaire, 2 mL of blood was drawn from each patient by venous 
puncture through a sterile procedure and collected into a vacutainer tube. Whole blood 
was centrifuged at 3000 rpm for 15 minutes to obtain a serum sample which was then 
stored in cryotubes at −20˚C within 24 hours of sampling. Enzyme-linked immunosor-
bent assay (ELISA; HAVAB-EIA; Abbot Diagnostics, Illinois, USA) was used to deter-
mine the presence of HAV antibodies. 
Data obtained were entered and analyzed using SPSS version 16.0 Chicago Illinois. 
Student t test was used for comparing qualitative variables. Logistic regression analysis 
was performed to determine the SES factors associated with anti-HAV antibodies posi-
tivity. P values <0.05 were considered statistically significant. 
3. Results 
Out of the 300 children, 256 were analyzed while forty four were excluded for not 
meeting the inclusion criteria. All the children were of African descent and boys were 
slightly more than girls (137 boys, 119 girls). The overall HAV antibodyseroprevalence 
in this population was 44.5%. The age distribution is shown in Table 2. 
There were 189 children from low SES and 107 from high SES with varied distribu-
tion as shown on Figure 1. 
 
Table 1. Risk factor attributes for hepatitis A virus.  
 1 2 
Type of house Permanent Semi permanent or Shanty 
Water supply Running tap in the house Running tap outside or communal well/river/from a vendor 
Sanitation Flush toilet in the house Communal flush toilet or pit latrine outside or no defined facility 
Crowded household Low crowded house (1 - 4 people) High crowded house (4 - 9 people) 
Parents level of  
education 
Both parents with secondary  
education and above 
1 or 2 parents with primary education 
or none 
Parents income High >$15 a day Low <$3 a day 
1 = High SES, 2 = Low SES. 
 
Table 2. Distribution of children according to age group. 
Age group Number Percentage 
2 - 4 80 31.3 
5 - 9 109 42.6 
10 - 14 67 26.2 
Total 256 100 
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When age specific seroprevalence of HAV antibodies were analyzed against socioe-
conomic status, it was found that generally children from a higher socioeconomic state 
had low antibody seroprevalence (Table 3). 
On subjecting variables of SES to logistic regression analysis, it was shown that fac-
tors associated with presence of HAV antibodies were related to age, crowding, parents 
income, residential area, source of water supply and parent’s level of education level in 
a descending order (Table 4). 
 
 
Figure 1. Distribution of children by age groups and socioeconomic states. 
 
Table 3. Age specific antibody seroprevalence of HAV. 
Age group Socioeconomic status % seroprevalence 
2 - 4 
High SES 3.8 
Low SES 37 
5 - 9 
High SES 14.6 
Low SES 61.8 
10 - 14 
High SES 38.9 
Low SES 77.6 
 
Table 4. Factors associated with presence of HAV antibodies. 
Factor 
% seronegativity 
P* Relative  risk 
Lower  
limit 
Upper 
limit High SES Low SES 
Parents income 71.4 32.3 <0.05 2.2 1.7 2.8 
Source of water 70.5 28.3 <0.05 2.5 2.8 3.4 
Residential area 66.9 30.2 <0.05 2.2 1.6 3.0 
Parents level of education 72.7 20.0 <0.05 3.6 2.4 5.6 
Crowded household 70.4 36.7 <0.05 1.9 1.5 2.4 
Age 73.2 34.6 <0.05 3.8 2.8 5.8 
P*: degree of significance. 
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4. Discussion 
The results of this study are in keeping with findings of previous studies [10] [11] [12] 
that HAV antibody seropositivity increased significantly with advancing age and was 
significantly different in every age group (P < 0.05). Our study indicates a significant 
shift in the pattern of HAV epidemiology in Kenya. In previous findings it was ob-
served that most African countries such as Kenya, had very high rates of HAV infection 
and nearly all children by the age of 5 years had been infected [13]. The epidemiological 
shift may be attributed to improved socioeconomic status, improved public sanitation, 
use of chlorinated water and increased level of parental education. Hepatitis A virus 
seroprevalence rate is directly related to socioeconomic development of a particular so-
ciety. For example, in developed countries such as North American states, Austria and 
Norway, seropositivity rates are low ranging from 2% and 20% in adolescence [14]. On 
the contrary, seropositivity rates in developing countries range between 50% and 100% 
until adult age and are related to poor socioeconomic development [15] [16] [17]. 
In deed when low and high socioeconomic status children are compared, the latter 
tend to have a pattern close to those of developed countries while the former have sim-
ilar patterns to those of developing nations (Table 5). 
Results from the current study shows that disease acquisition among the high SES 
population occurs in early adolescence and may proceed on to early adulthood rather 
than in early childhood. This may coincide with young adults’ closer interaction at 
school, involvement in risky behaviours such as poor hand hygiene and interacting 
more and more with street populations [1] [2] [18]. The implication is that a low level 
of HAV immunity among young adult population puts them at a higher risk of out-
breaks and severer symptomatic infections [13] [19]. 
 
Table 5. The HAV antibody seroprevalence age groups in several countries. 
Country Age group (years) HAV seroprevalence 
United Kingdom  
(Das et al., 2000) 
5 - 9 10.5 
10 - 14 13.9 
15 - 19 19.6 
Italy (Fix et al., 2002) 
3 - 5 2.3 
17 - 19 16.3 
India (Baudin et al., 1971) 
6 - 10 62.2 
11 - 15 68.5 
Over 16 80.8 
Current study (Kenya) 
Low SES High SES 
5 - 9 61.8 
10 - 14 77.6 
5 - 9 14.6 
10 - 14 38.9 
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This study reported a negative correlation between parental education level and 
HAV antibody seroprevalence. This has also been observed in other previous studies 
[17] [20]. It has been noted that parental education level has a direct effect on lifestyle 
led by the family through influencing sanitation, living in a less crowded area and thus 
being accessible to portable treated water [21]. On the contrary children from a low 
SES, whose parental level of education was low, may have been exposed to negative en-
vironmental factors that facilitated hepatitis A transmission and hence infection.  
Notable is that HAV vaccines that have been available just before the beginning of 
the millennium providing consistent and long-lasting protection [22] have not been 
fully utilized in our setting. Countries such as the United States where vaccination pro-
grams have been executed in high endemic areas have reported very low outbreaks of 
HAV infections amongst young adults [9]. In Kenya, our national immunization pro-
gram does not include HAV vaccine. We recommend that vaccination against HAV in 
preschool-aged children and more so children from higher SES settings should be con-
sidered to mitigate future morbidity and mortality arising from HAV infection. 
5. Conclusion and Recommendation 
These results show a considerable rate of HAV antibody seronegativity amongst the 
studied population especially those from richer backgrounds making them more sus-
ceptible to severe infection in future, with concomitant complications. We propose that 
revision of National Vaccination Program should be considered to include Hepatitis A 
vaccination. 
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